DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
ADA361697
Title:
Ret Receptor: Functional Consequences of Oncogenic Rearrangements
Descriptive Note:
Final rept. 15 Sep 94-14 Sep 98
Corporate Author:
CALIFORNIA UNIV SAN DIEGO LA JOLLA
Report Date:
1998-10-01
Pagination or Media Count:
44.0
Abstract:
The retptc2 gene was cloned from human papillary thyroid carcinomas, and is the product of a reciprocal chromosomal rearrangement, translocation event between the cAMP dependent protein kinase regulatory subunit I alpha RI alpha and the tyrosine kinase domain of the Ret receptor. Retptc2 is a dimer which is autophosphorylated, soluble, and constitutively active. We generated a computer model of the Retptc2 kinase domain, expressed and purified Retptc2, developed a kinase assay to test a variety of peptide substrates and a microinjection assay to compare the structure function relationship of Retptc2 mutants. A number of tyrosine residues within the Retptc2 kinase domain as well as the RI alpha dimerization domain are critical for eliciting a mitogenic response.
Distribution Statement:
APPROVED FOR PUBLIC RELEASE